Literature DB >> 16855531

Behavioral sensitization, alternative splicing, and d3 dopamine receptor-mediated inhibitory function.

Neil M Richtand1.   

Abstract

Behavioral sensitization, the progressive and enduring augmentation of certain behaviors following repetitive drug use, alters rodent locomotion in a long-standing manner. The same dopamine pathways playing an important role in drug dependence and psychosis also play a critical role in sensitization. Individual dopamine receptor subtypes have markedly different functional responses to stimulation, with D3 dopamine receptor stimulation inhibiting rodent locomotion. The D3 receptor has highest affinity of the dopamine receptor subtypes for dopamine, and is occupied to a greater degree following stimulant drug administration. D3 receptor activity may be regulated through the expression of an alternatively spliced, truncated receptor isoform (termed 'D3nf') altering receptor localization and function via dimerization with the full-length subunit. The expected physiological response to repetitive drug administration is tolerance. Tolerance of D3 receptor inhibition of locomotion would contribute to sensitization to stimulant drugs. We hypothesize that repetitive D3 receptor stimulation contributes to the development of behavioral sensitization through decreased responsivity of D3-receptor-mediated locomotor inhibition. Increased D3nf expression may direct altered receptor localization and subsequent release of D3-receptor-mediated inhibition, contributing to the expression of sensitization. These hypotheses follow directly from the affinities of the receptor subtypes for dopamine; dopamine concentrations following stimulant administration; the effects of individual dopamine receptor subtype stimulation on locomotion; and the expected homeostatic response of the system to perturbation by drug. Clarifying these mechanisms underlying sensitization may suggest new interventions for neuropsychiatric conditions in which dopamine plays an important role, including psychosis, drug dependence, and Parkinson's disease. This information may also elucidate a previously unrecognized mechanism regulating receptor trafficking and desensitization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16855531      PMCID: PMC1815380          DOI: 10.1038/sj.npp.1301163

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  101 in total

Review 1.  Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity.

Authors:  J A Lieberman; B B Sheitman; B J Kinon
Journal:  Neuropsychopharmacology       Date:  1997-10       Impact factor: 7.853

2.  Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities.

Authors:  D M Segal; C T Moraes; D C Mash
Journal:  Brain Res Mol Brain Res       Date:  1997-05

3.  Effects of intermittent and continuous cocaine administration on dopamine release and uptake regulation in the striatum: in vitro voltammetric assessment.

Authors:  S R Jones; T H Lee; R M Wightman; E H Ellinwood
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

Review 4.  The neural basis of drug craving: an incentive-sensitization theory of addiction.

Authors:  T E Robinson; K C Berridge
Journal:  Brain Res Brain Res Rev       Date:  1993 Sep-Dec

5.  Characterization of a novel exon within the D3 receptor gene giving rise to an mRNA isoform expressed in rat brain.

Authors:  S Pagliusi; A Chollet-Daemerius; C Losberger; A Mills; E Kawashima
Journal:  Biochem Biophys Res Commun       Date:  1993-07-15       Impact factor: 3.575

6.  Enhanced cleavage of an atypical intron of dopamine D3-receptor pre-mRNA in chronic schizophrenia.

Authors:  C Schmauss
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

7.  Functional and anatomical evidence for different dopamine dynamics in the core and shell of the nucleus accumbens in slices of rat brain.

Authors:  S R Jones; S J O'Dell; J F Marshall; R M Wightman
Journal:  Synapse       Date:  1996-07       Impact factor: 2.562

8.  Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities.

Authors:  J K Staley; D C Mash
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

9.  Coordinated expression of dopamine receptors in neostriatal medium spiny neurons.

Authors:  D J Surmeier; W J Song; Z Yan
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

10.  Enhancement of postsynaptic sensitivity to dopaminergic agonists induced by neonatal hippocampal lesions.

Authors:  R Q Wan; R Corbett
Journal:  Neuropsychopharmacology       Date:  1997-04       Impact factor: 7.853

View more
  29 in total

1.  Relative expression of D3 dopamine receptor and alternative splice variant D3nf mRNA in high and low responders to novelty.

Authors:  Laurel M Pritchard; Aaron D Logue; Benjamin C Taylor; Rebecca Ahlbrand; Jeffrey A Welge; Yang Tang; Frank R Sharp; Neil M Richtand
Journal:  Brain Res Bull       Date:  2006-07-13       Impact factor: 4.077

2.  Estradiol impairs response inhibition in young and middle-aged, but not old rats.

Authors:  Victor C Wang; Steven L Neese; Donna L Korol; Susan L Schantz
Journal:  Neurotoxicol Teratol       Date:  2011-01-28       Impact factor: 3.763

3.  Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44.

Authors:  Martin Weber; Wei-Li Chang; John P Durbin; Paula E Park; Robert R Luedtke; Robert H Mach; Neal R Swerdlow
Journal:  Pharmacol Biochem Behav       Date:  2009-05-06       Impact factor: 3.533

4.  Heightened Dopaminergic Response to Amphetamine at the D3 Dopamine Receptor in Methamphetamine Users.

Authors:  Isabelle Boileau; Doris Payer; Pablo M Rusjan; Sylvain Houle; Junchao Tong; Tina McCluskey; Alan A Wilson; Stephen J Kish
Journal:  Neuropsychopharmacology       Date:  2016-06-29       Impact factor: 7.853

Review 5.  Alternative splicing of G protein-coupled receptors: physiology and pathophysiology.

Authors:  Danijela Markovic; R A John Challiss
Journal:  Cell Mol Life Sci       Date:  2009-07-23       Impact factor: 9.261

6.  Dopaminergic regulation of dopamine D3 and D3nf receptor mRNA expression.

Authors:  Neil M Richtand; Yanhong Liu; Rebecca Ahlbrand; Juliana R Sullivan; Amy Hauck Newman; Robert K McNamara
Journal:  Synapse       Date:  2010-08       Impact factor: 2.562

7.  C57BL/6J mice exhibit reduced dopamine D3 receptor-mediated locomotor-inhibitory function relative to DBA/2J mice.

Authors:  R K McNamara; B Levant; B Taylor; R Ahlbrand; Y Liu; J R Sullivan; K Stanford; N M Richtand
Journal:  Neuroscience       Date:  2006-08-28       Impact factor: 3.590

8.  A functional role for the dopamine D3 receptor in the induction and expression of behavioural sensitization to ethanol in mice.

Authors:  Sarah Jane Harrison; José N Nobrega
Journal:  Psychopharmacology (Berl)       Date:  2009-08-07       Impact factor: 4.530

9.  Differential susceptibility to ethanol and amphetamine sensitization in dopamine D3 receptor-deficient mice.

Authors:  Sarah Jane Harrison; José N Nobrega
Journal:  Psychopharmacology (Berl)       Date:  2008-12-19       Impact factor: 4.530

10.  The reward system and maternal behavior in an animal model of depression: a microdialysis study.

Authors:  Yael Lavi-Avnon; Aron Weller; John P M Finberg; Iris Gispan-Herman; Noa Kinor; Yaakov Stern; Mariana Schroeder; Vered Gelber; S Yoav Bergman; David H Overstreet; Gal Yadid
Journal:  Psychopharmacology (Berl)       Date:  2007-10-11       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.